Back

Prof. dr. M.G.E.M. Ausems

Prof. dr. M.G.E.M. Ausems

Full Professor
Prof. dr. M.G.E.M. Ausems
  • Section Clinical Genetics

Research Programs

Strategic Program Cancer

Side Activities

Lid Adviesraad Borstkankervereniging Nederland

Lid Raad van Advies ProstaatkankerStichting

Incidenteel lid Adviesraad AstraZeneca 

Lid KADI (Key Area Driven Initiatives) commissie KWF Kankerbestrijding.

Research Output (239)

Oncogenetica

Suerink Manon, Bleiker Eveline M.A., Nielsen Maartje, Houwink Elisa J.F., Baas Jara M., Ausems Margreet G.E.M. 5 Jan 2023, In: Nederlands Tijdschrift voor Geneeskunde. 167 10 p.

Mainstream germline genetic testing in men with metastatic prostate cancer:design and protocol for a multicenter observational study

Vlaming Michiel, Bleiker Eveline M.A., van Oort Inge M., Kiemeney Lambertus A.L.M., Ausems Margreet G.E.M. 30 Dec 2022, In: BMC Cancer. 22 , p. 1-9 9 p.

Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy

Terra Lara, Beekman Maarten J, Engelhardt Ellen G, Heemskerk-Gerritsen Bernadette A M, Van Beurden Marc, Roeters Van Lennep Jeanine E, Van Doorn Helena C, De Hullu Joanne A, Van Dorst Eleonora B L, Mom Constantijne H, Slangen Brigitte F M, Gaarenstroom Katja N, van der Kolk Lizet E, Margriet Collée J, Wevers Marijke R, Ausems Margreet G E M, Van Engelen K, Van De Beek I, Berger Lieke P V, Van Asperen Christi J, Gomez Garcia Encarna B, Maas Angela H E M, Hooning Maartje J, Aaronson Neil K, Mourits Marian J E, Van Leeuwen Flora E 17 Nov 2022, In: American Journal of Obstetrics and Gynecology. 228 , p. 440.e1-440.e20

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing

Bokkers Kyra, Bleiker Eveline M.A., Hoogendam Jacob P., Velthuizen Mary E., Schreuder Henk W.R., Gerestein Cornelis G., Lange Joost G., Louwers Jacqueline A., Koudijs Marco J., Ausems Margreet G.E.M., Zweemer Ronald P. 8 Sep 2022, In: Hereditary Cancer in Clinical Practice. 20

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective

Bokkers K, Frederix G W J, Velthuizen M E, van der Aa M, Gerestein C G, van Dorst E B L, Lange J G, Louwers J A, Koole W, Zweemer R P, Ausems M G E M 25 Aug 2022, In: Gynecologic Oncology. 167 , p. 115-122 8 p.

Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry

Dumont Martine, Weber-Lassalle Nana, Joly-Beauparlant Charles, Ernst Corinna, Droit Arnaud, Feng Bing Jian, Dubois Stéphane, Collin-Deschesnes Annie Claude, Soucy Penny, Vallée Maxime, Fournier Frédéric, Lemaçon Audrey, Adank Muriel A., Allen Jamie, Altmüller Janine, Arnold Norbert, Ausems Margreet G.E.M., Berutti Riccardo, Bolla Manjeet K., Bull Shelley, Carvalho Sara, Cornelissen Sten, Dufault Michael R., Dunning Alison M., Engel Christoph, Gehrig Andrea, Geurts-Giele Willemina R.R., Gieger Christian, Green Jessica, Hackmann Karl, Helmy Mohamed, Hentschel Julia, Hogervorst Frans B.L., Hollestelle Antoinette, Hooning Maartje J., Horváth Judit, Ikram M. Arfan, Kaulfuß Silke, Keeman Renske, Kuang Da, Luccarini Craig, Maier Wolfgang, Martens John W.M., Niederacher Dieter, Nürnberg Peter, Ott Claus Eric, Peters Annette, Pharoah Paul D.P., Ramirez Alfredo, van der Luijt Rob B., , 2 Jul 2022, In: Cancers. 14 , p. 1-23

Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study

van Barele Mark, Rieborn Amy, Heemskerk-Gerritsen Bernadette A.M., Obdeijn Inge Marie, Koppert Linetta B., Loo Claudette E., Tollenaar Rob A.E.M., Ausems Margreet G.E.M., van de Beek Irma, Berger Lieke P.V., de Boer Maaike, van Hest Liselot P., Kets C. Marleen, Rookus Matti, Schmidt Marjanka K., Jager Agnes, Hooning Maartje J., Jul 2022, In: Breast Cancer Research and Treatment. 194 , p. 159-170 12 p.

Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?

Patuleia Susana I S, Moelans Cathy B, Koopman Jasmijn, van Steenhoven Julia E C, van Dalen Thijs, van der Pol Carmen C, Jager Agnes, Ausems Margreet G E M, van Diest Paul J, van der Wall Elsken, Suijkerbuijk Karijn P M 27 Jun 2022, In: BMC Cancer. 22 , p. 1-8

The Feasibility of Implementing Mainstream Germline Genetic Testing in Routine Cancer Care—A Systematic Review

Bokkers Kyra, Vlaming Michiel, Engelhardt Ellen G., Zweemer Ronald P., van Oort Inge M., Kiemeney Lambertus A.L.M., Bleiker Eveline M.A., Ausems Margreet G.E.M. 2 Feb 2022, In: Cancers. 14 , p. 1-15

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers:A nationwide cohort study

Akdeniz Delal, van Barele Mark, Heemskerk-Gerritsen Bernadette A.M., Steyerberg Ewout W., Hauptmann Michael, van de Beek Irma, van Engelen Klaartje, Wevers Marijke R., Gómez García Encarnacion B., Ausems Margreet G.E.M., Berger Lieke P.V., van Asperen Christi J., Adank Muriel A., Collée Margriet J., Stommel-Jenner Denise J., Jager Agnes, Schmidt Marjanka K., Hooning Maartje J., Feb 2022, In: Breast. 61 , p. 98-107 10 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet